Metraipolis › archive › dc_7ec27bf36afb

Impact of Imatinib Intake Timing on Oncological Outcomes in Metastatic Gastrointestinal Stromal Tumors (GISTs): A Retrospective Single-Institute Study — Europe PMC PMID:42371467

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42371467
DOI
10.7759/cureus.109890
License (as archived)
solo-consultazione
Archived
2026-11-01T04:37:46.772Z
SHA-256 of the archived text
0aa8f9522e7ad9f683b0ab7f4c322f2607665de54888dc3da7f674a71d4ded91
Stable URL of this page
https://metraipolis.com/documento/dc_7ec27bf36afb

How to cite

Impact of Imatinib Intake Timing on Oncological Outcomes in Metastatic Gastrointestinal Stromal Tumors (GISTs): A Retrospective Single-Institute Study — Europe PMC PMID:42371467 — Europe PMC (en), https://europepmc.org/article/MED/42371467 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ec27bf36afb (Metraipolis archive dc_7ec27bf36afb, sha256 0aa8f9522e7ad9f683b0ab7f4c322f2607665de54888dc3da7f674a71d4ded91)
BibTeX
@misc{dc7ec27bf36afb,
  title = {Impact of Imatinib Intake Timing on Oncological Outcomes in Metastatic Gastrointestinal Stromal Tumors (GISTs): A Retrospective Single-Institute Study — Europe PMC PMID:42371467},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42371467},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ec27bf36afb; sha256 0aa8f9522e7ad9f683b0ab7f4c322f2607665de54888dc3da7f674a71d4ded91},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42371467. Agents can read the archived copy with the MCP tool read_document.